StrataGraft skin substitute is well-tolerated and is not acutely immunogenic in patients with traumatic wounds: results from a prospective, randomized, controlled dose escalation trial.
- DOI
- 10.1097/sla.0b013e318210f3bd
- Published
- 2011 Apr
- Container
- Annals of surgery
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1097/sla.0b013e318210f3bd,
title = {StrataGraft skin substitute is well-tolerated and is not acutely immunogenic in patients with traumatic wounds: results from a prospective, randomized, controlled dose escalation trial.},
author = {Centanni JM and Straseski JA and Wicks A and Hank JA and Rasmussen CA and Lokuta MA and Schurr MJ and Foster KN and Faucher LD and Caruso DM and Comer AR and Allen-Hoffmann BL},
year = {2011},
journal = {Annals of surgery},
doi = {10.1097/sla.0b013e318210f3bd},
url = {https://doi.org/10.1097/sla.0b013e318210f3bd}
}RIS
TY - JOUR TI - StrataGraft skin substitute is well-tolerated and is not acutely immunogenic in patients with traumatic wounds: results from a prospective, randomized, controlled dose escalation trial. AU - Centanni JM AU - Straseski JA AU - Wicks A AU - Hank JA AU - Rasmussen CA AU - Lokuta MA AU - Schurr MJ AU - Foster KN AU - Faucher LD AU - Caruso DM AU - Comer AR AU - Allen-Hoffmann BL PY - 2011 JO - Annals of surgery DO - 10.1097/sla.0b013e318210f3bd UR - https://doi.org/10.1097/sla.0b013e318210f3bd ER -
APA
JM, C., JA, S., A, W., JA, H., CA, R., MA, L., MJ, S., KN, F., LD, F., DM, C., AR, C., & BL, A. (2011). StrataGraft skin substitute is well-tolerated and is not acutely immunogenic in patients with traumatic wounds: results from a prospective, randomized, controlled dose escalation trial.. Annals of surgery. https://doi.org/10.1097/sla.0b013e318210f3bd
Source records
- pubmed · retrieved 2026-09-26T04:39:47.507Z